Migraine: A “woman’s disease?”

Women and Health

Volumn 28, Issue 2, 1999, Pages 79-99

  Warshaw, Leon J ^a   Lipton, Richard B ^b,c   Silberstein, Stephen D ^d,e  

^a NEW YORK UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e JEFFERSON HEADACHE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMAN; MIGRAINE; REVIEW; SEX DIFFERENCE; WOMEN'S HEALTH; ACADEMIC ACHIEVEMENT; ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE SEVERITY; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG COST; ECONOMIC ASPECT; ENTERIC COATED TABLET; HEADACHE; HEALTH BEHAVIOR; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; JOB PERFORMANCE; MENARCHE; MENOPAUSE; MENSTRUATION; NAUSEA; OPIATE ADDICTION; ORAL DRUG ADMINISTRATION; OVARIECTOMY; PATIENT CARE; PREGNANCY; RECTAL DRUG ADMINISTRATION; RELAXATION TRAINING; SEXUAL BEHAVIOR; SOCIAL INTERACTION; SUBCUTANEOUS DRUG ADMINISTRATION; SUPPOSITORY; TRANSDERMAL DRUG ADMINISTRATION; VOMITING;

FEMALE; HUMANS; MIGRAINE DISORDERS; SEX FACTORS; WOMEN'S HEALTH;

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; BUTALBITAL; BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL; BUTORPHANOL TARTRATE; CAFERGOT; CALCIUM CHANNEL BLOCKING AGENT; DANAZOL; DIHYDROERGOTAMINE MESILATE; ERGOTAMINE TARTRATE; ESTROGEN; EXCEDRIN; ISOMETHEPTENE MUCATE; METHYSERGIDE MALEATE; METOCLOPRAMIDE; MONOAMINE OXIDASE INHIBITOR; NADOLOL; NAPROXEN; NARATRIPTAN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; ORAL CONTRACEPTIVE AGENT; PROPRANOLOL; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SUMATRIPTAN; TAMOXIFEN; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROATE SEMISODIUM; VERAPAMIL; WIGRAINE;

EID: 0032216653     PISSN: 03630242     EISSN: 15410331     Source Type: Journal    
DOI: 10.1300/J013v28n02_05     Document Type: Article

References (52)

1. Stewart, W.F., and Lipton, R.B., 1993. “Social impact of headache.”. In The Headaches, Edited by:Olesen, J., Tfelt-Hansen, P., and Welch, K.M.A., 29–34. New York:Raven Press.
2. Lipton, R.B., Stewart, W.F., and von Korff, M., 1997. Burden of migraine:Societal costs and therapeutic opportunities. Neurology, 48(suppl 3):S4–S9.
3. Lidell, J., 1995. Migraine:The patient's perspective. Rev Contemp Pharmacother, 5:253–257.
4. Macgregor, E.A., 1997. The doctor and the migraine patient:Improving compliance. Neurology, 48(suppl 3), S16-S20
5. Stewart, W.F., Schechter, A., and Lipton, R.B., 1993. Migraine heterogenicity:Disability, pain intensity, and attack frequency and attack duration. Neurology, 44(suppl 4), S24-S29
6. Headache Classification Committee of the International Headache Society. 1988. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia, 1(suppl 7):1–96.
7. Olesen, J., and Rasmussen, B.K., 1997. “Classification of migraine.”. In Headache, Edited by:Goadsby, P.J., and Silberstein, S.D., 97–105. Boston:Butterworth-Heinemann.
8. Spierings, E.L., Sorbi, M., Haimowitz, B.R., and Tellegen, B., 1996. Changes in daily hassles, mood and sleep in the 2 days before a migraine headache. Clin J Pain, 12:38–42.
9. Galiano, L., Monteil, I., Falip, R., Asensio, M., and Matias-Guiu, J., 1995. Stress as a precipitating factor in migraine. Rev Neurol, 23:830–832.
10. Stewart, W.F., Schechter, A., and Rasmussen, B.K., 1994. Migraine prevalence:A review of population-based studies. Neurology, 44(suppl 4):S17–S23.
11. Stewart, W.F., Lipton, R.B., Celentano, D.D., and Reed, M.L., 1992. Prevalence of migraine headache in the United States:Relation to age, income, race, and other socio-demographic factors. JAMA, 267:63–69.
12. Lipton, R.B., and Stewart, W.F., 1993. Migraine in the United States:A review of epidemiology and health care use. Neurology, 43(suppl 3), S6-S10
13. Upton, R.B., Stewart, W.F., Celentano, D.D., and Reed, M.L., 1992. Undiagnosed migraine headaches:A comparison of symptom-based and reported physician diagnosis. Arch Int Med, 152:1273–1278.
14. Stang, P.E., Osterhaus, J.T., and Celentano, D.D., 1994. Migraine:Patterns of health care use. Neurology, 44(suppl 4):S47–S55.
15. Silberstein, S.D., 1995. Migraine and women:The link between headache and hormones. Postgrad Med, 97:147–153.
16. Granella, F., Sances, G., Zanferrari, C., Costa, A., Martignoni, E., and Manzoni, G.C., 1993. Migraine without aura and reproductive live events:A clinical epidemiological study in 1, 300 women. Headache, 33:385–389.
17. Johannes, C.B., Linet, M.S., Stewart, W.F., Celentano, D.D., Lipton, R.B., and Szklo, M., 1995. Relationship of headache to phase of the menstrual cycle among young women:A daily diary study. Neurology, 45:1076–1082.
18. Bousser, M., and Massiou, H., 1993. “Migraine in the reproductive cycle.”. In The Headaches, Edited by:Olesen, J., Tfelt-Hansen, P., and Welch, K.M.A., 413–419. New York:Raven Press Ltd.
19. Marcus, D.A., 1995. Clinical review:Interrelationships of neurochemicals, estrogen and recurring headache. Pain, 62:129–139.
20. Silberstein, S.D., and Merriam, G.R., 1997. “Sex hormones and headache.”. In Headache, Edited by:Goadsby, P.J., and Silberstein, S.D., 143–173. Boston:Butterworth-Heinemann.
21. Couch, J.R., and Bearss, C.M., 1987. Relief of migraine headache with sexual orgasm. Headache, 27:287
22. Chen, T.C., and Leviton, A., 1994. Headache recurrence in pregnant women with migraine. Headache, 34:107–110.
23. Maggioni, F., Alessi, C., Maggioni, T., and Zanchin, G., 1997. Headache during pregnancy. Cephalalgia, 17:765–769.
24. Silberstein, S.D., 1993. Headaches and women:Treatment of the pregnant or lactating migraineur. Headache, 33:533–540.
25. Wainscott, G., Sullivan, F.M., Volans, G.N., and Wilkinson, M., 1978. The outcome of pregnancy in women suffering from migraine. Postgrad Med J, 54:98–102.
26. Lipton, R.B., Stewart, W.F., and Simon, D., 1998. Medical consultation for migraine:Results from the American Migraine Study. Neurology, (in press)
27. Celentano, D.D., Stewart, W.F., Lipton, R.B., and Reed, M.L., 1992. Medication use and disability among migraineurs:A national probability sample survey. Headache, 32:223–228.
28. Lipton, R.B., Amatniek, J.C., Ferrari, M.D., and Gross, M., 1994. Migraine:Identifying and removing barriers to care. Neurology, 44(suppl 4):S63–S68.
29. Sorbi, M., Telegen, B., and du Long, A., 1989. Long-term effects of training in relaxation and stress coping in patients with migraine:A 3-year follow-up. Headache, 29:111–121.
30. McGrath, P.J., and Sorbi, M., 1993. “Psychological treatments”. In The Headaches, Edited by:Olesen, J., Tfelt-Hansen, P., and Welch, K.M.A., 289–294. New York:Raven Press Ltd.
31. Lance, J.W., 1997. “Preventive treatment in migraine”. In Headache, Edited by:Goadsby, P.J., and Silberstein, S.D., 131–142. Boston:Butterworth-Heinemann.
32. Silberstein, S.D., and Merriam, G.R., 1997. “Sex hormones and headache”. In Headache, Edited by:Goadsby, P.J., and Silberstein, S.D., 143–173. Boston:Butterworth-Heinemann.
33. Newman, L.C., Lipton, R.B., Lay, C.L., and Solomon, S., 1997. An open-label pilot study of oral sumatriptan in the intermittent prophylaxis of menstrual migraine. Cephalalgia, 17:437–438.
34. Herzog, A.G., 1997. Continuous bromocriptine therapy in menstrual migraine. Neurology, 48:101–102.
35. Ziegler, D.K., 1987. “The treatment of migraine”. In Wolff's Headache and Other Head Pain, 5th Edition, Edited by:Dalessio DJ, J.D., 87–111. New York:Oxford University Press.
36. Adelman, J.U., and Von Zeggern, R., 1955. Cost considerations in headache treatment. Part I:Prophylactic migraine treatment. Headache, 35:479–487.
37. Tfelt-Hansen, P., and Johnson, E.S., 1993. “Nonsteroidal anti-inflammatory drugs in the treatment of the acute migraine attack”. In The Headaches, Edited by:Olesen, J., Tfelt-Hansen, P., and Welch, K.M.A., 305–311. New York:Raven Press Ltd.
38. Lipton, R.B., Stewart, W.F., Ryan, R.E., Jr., Saper, J., Silberstein, S.D., and Sheftell, F., 1998. Efficacy and safety of acetaminophen, aspirin and caffeine in alleviating headache pain:three double-blind, randomized, placebo-controlled trials. Arch Neurol, 55:210–217.
39. Volans, G.N., 1975. The effects of metoclopramide on the absorption of effervescent aspirin in migraine. Brit J Clin Pharmacol, 2:57–63.
40. Capobianco, D.J., Cheshire, W.P., and Campbell, J.K., 1996. An overview of the diagnosis and pharmacologic treatment of migraine. Mayo Clinic Proc, 71:1055–1066.
41. The Multinational Oral Sumatriptan and Cafergot International Study Group. 1991. A randomized, double-blind comparison of sumatriptan and cafergot in the acute treatment of migraine. Eur Neurol, 31:314–322.
42. Cady, R.K., Wendt, J.K., Kirchner, J.R., Sargent, J.D., Rothrock, J.F., and Jr, Skaggs, H., 1991. Treatment of migraine with subcutaneous sumatriptan. JAMA, 265:2831–2835.
43. The Subcutaneous Sumatriptan International Study Group. 1991. Treatment of migraine attacks with sumatriptan. N Eng J Med, 325:316–321.
44. Legg, R.F., Sclar, D.A., Nemec, N.L., Tarnai, J., and Mackowiak, J.I., 1997. Cost benefit of sumatriptan to an employer. J Occup Environ Med, 30:652–657.
45. Goadsby, P.J., and Olesen, J., 1997. Increasing the options for effective migraine management. Neurology, 48(suppl 3), S1-S3
46. Hoffert, M.J., Couch, J.R., Diamond, S., Elkind, A.H., Goldstein, J., Kohlerman, N.J., 3rd, Saper, J.R., and Solomon, S., 1955. Transnasal butorphanol in the treatment of acute migraine. Headache, 35:65–69.
47. Neri, I., Granella, N.T., Nappi, F., Manzoni, G.C., Facchinetti, F., and Genazzani, A.R., 1993. Characteristics of headache at menopause:A clinico-epidemiologic study. Maturitas, 17:31–37.
48. Casson, P., Hahn, P.M., Van Vugt, D.A., and Reid, R.L., 1990. Lasting response to ovariectomy in women with severe premenstrual syndrome. Am J Obstet Gynecol, 162:99–105.
49. Caspar, R.F., and Hearn, M.T., 1990. The effect of hysterectomy and bilateral oophorectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol, 162:105–109.
50. Olesen, J., 1995. Analgesic headache. A common treatable condition that deserves more attention. Br Med J, 310:479–480.
51. Gooddy, W., 1992. “Foreword to the original (1970) edition”. In Migraine:Revised and Expanded, Edited by:Sacks, O., Berkeley:University of California Press. (pp. xxi-xxiii)
52. Mencken, M., 1996. Commentary on “Intranasal lidocaine relieved acute migraine pain. ACP Journal Club, 126:319–321. Comment on:Maizels, M., Scott, B., Cohen, W., & Chen. W, 1997 17. Intranasal lidocaine for treatment of migraine:A randomized double-blind controlled trial. JAMA, 276